Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
CERE holding history
Cerevel Therapeutics Holdings, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERE overviewAll 13F holders of CEREFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −332,597−100.0% | Sold out | Holders |
| Q2 2023 | 332,597 | $10.6M | <0.1% | −305−0.1% | Reduced | Holders |
| Q1 2023 | 332,902 | $8.12M | <0.1% | −788,664−70.3% | Reduced | Holders |
| Q4 2022 | 1,121,566 | $35.4M | 0.1% | +35,610+3.3% | Added | Holders |
| Q3 2022 | 1,085,956 | $30.7M | 0.1% | +82,992+8.3% | Added | Holders |
| Q2 2022 | 1,002,964 | $26.5M | 0.1% | +273,114+37.4% | Added | Holders |
| Q1 2022 | 729,850 | $25.6M | 0.1% | +685+0.1% | Added | Holders |
| Q4 2021 | 729,165 | $23.6M | 0.1% | +729,165 | New | Holders |